{"organizations": [], "uuid": "cad4be3ce525cf98d77e66119c2605421a0d0d0f", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-inspiremd-enters-distribution-sale/brief-inspiremd-enters-distribution-sales-marketing-agreement-for-cguard-eps-in-south-korea-idUSFWN1QC0WJ", "country": "US", "domain_rank": 408, "title": "BRIEF-InspireMD Enters Distribution, Sales & Marketing Agreement For Cguard EPS In South Korea", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-22T17:45:00.000+02:00", "replies_count": 0, "uuid": "cad4be3ce525cf98d77e66119c2605421a0d0d0f"}, "author": "", "url": "https://www.reuters.com/article/brief-inspiremd-enters-distribution-sale/brief-inspiremd-enters-distribution-sales-marketing-agreement-for-cguard-eps-in-south-korea-idUSFWN1QC0WJ", "ord_in_thread": 0, "title": "BRIEF-InspireMD Enters Distribution, Sales & Marketing Agreement For Cguard EPS In South Korea", "locations": [], "entities": {"persons": [], "locations": [{"name": "south korea", "sentiment": "none"}, {"name": "south korea", "sentiment": "none"}], "organizations": [{"name": "cguard eps in south korea reuters", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 22 (Reuters) - InspireMD Inc:\n* INSPIREMD ANNOUNCES EXCLUSIVE DISTRIBUTION, SALES AND MARKETING AGREEMENT FOR CGUARD EPS IN SOUTH KOREA\n* SAYS ‍AGREEMENT GRANTS SOLVIT EXCLUSIVE RIGHT TO MARKET AND SELL CO‘S CGUARD EPS FOR TREATMENT OF CAROTID DISEASE UPON KOREAN MFDS APPROVAL​\n* SAYS SOLVIT WILL FUND AND MANAGE REGISTRATION AND REIMBURSEMENT SUBMISSIONS FOR CGUARD™ EPS IN SOUTH KOREA\n* SAYS ‍TERM OF AGREEMENT EXTENDS FOR FIVE YEARS FOLLOWING REGULATORY APPROVAL IN SOUTH KOREA​ Source text for Eikon: Further company coverage:\n ", "external_links": [], "published": "2018-02-22T17:45:00.000+02:00", "crawled": "2018-02-22T18:01:05.004+02:00", "highlightTitle": ""}